Mónica S. Estevão
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mónica S. Estevão has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Maria Manuel B. Marques
LAQV REQUIMTE, Department of Chemistry, NOVA School of Science and Technology | NOVA FCT, Portugal
6 shared publications - Eduarda Fernandes
University of Porto
5 shared publications - Luísa C. R. Carvalho
REQUIMTE-CQFB, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal
5 shared publications - Carlos Alberto Mateus Afonso
Research Institute for Medicines (iMed.ULisboa) Faculty of Pharmacy Universidade de Lisboa Lisbon Portugal
4 shared publications - Luisa Maria Ferreira
LAQV‐REQUIMTE, Chemistry Department NOVA School of Science and Technology (NOVA FCT) Caparica Portugal
3 shared publications Ana Gomes
2 shared publications
Latest Publications
- Open Access
- 14 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (4) , 1612
Correction: Oliveira et al. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice. Int. J. Mol. Sci. 2021, 22, 5289
- 14 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (4) , 1612
Open AccessCorrection: Oliveira et al. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice. Int. J. Mol. Sci. 2021, 22, 5289
- Open Access
- 18 May 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (10) , 5289
Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, mainly characterized by motor deficits correlated with progressive dopaminergic neuronal loss in the substantia nigra pars compacta (SN). Necroptosis is a caspase-independent form of regulated cell death mediated by the concerted action of receptor-interacting protein 3 (RIP3) and the pseudokinase mixed lineage domain-like protein (MLKL). It is also usually dependent on RIP1 kinase activity, influenced by further cellular clues. Importantly, necroptosis appears to be strongly linked to several neurodegenerative diseases, including PD. Here, we aimed at identifying novel chemical inhibitors of necroptosis in a PD-mimicking model, by conducting a two-step screening. Firstly, we phenotypically screened a library of 31 small molecules using a cellular model of necroptosis and, thereafter, the hit compound effect was validated in vivo in a sub-acute 1-methyl-1-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) PD-related mouse model. From the initial compounds, we identified one hit—Oxa12—that strongly inhibited necroptosis induced by the pan-caspase inhibitor zVAD-fmk in the BV2 murine microglia cell line. More importantly, mice exposed to MPTP and further treated with Oxa12 showed protection against MPTP-induced dopaminergic neuronal loss in the SN and striatum. In conclusion, we identified Oxa12 as a hit compound that represents a new chemotype to tackle necroptosis. Oxa12 displays in vivo effects, making this compound a drug candidate for further optimization to attenuate PD pathogenesis.
- 18 May 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (10) , 5289
Open AccessDiscovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, mainly characterized by motor deficits correlated with progressive dopaminergic neuronal loss in the substantia nigra pars compacta (SN). Necroptosis is a caspase-independent form of regulated cell death mediated by the concerted action of receptor-interacting protein 3 (RIP3) and the pseudokinase mixed lineage domain-like protein (MLKL). It is also usually dependent on RIP1 kinase activity, influenced by further cellular clues. Importantly, necroptosis appears to be strongly linked to several neurodegenerative diseases, including PD. Here, we aimed at identifying novel chemical inhibitors of necroptosis in a PD-mimicking model, by conducting a two-step screening. Firstly, we phenotypically screened a library of 31 small molecules using a cellular model of necroptosis and, thereafter, the hit compound effect was validated in vivo in a sub-acute 1-methyl-1-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) PD-related mouse model. From the initial compounds, we identified one hit—Oxa12—that strongly inhibited necroptosis induced by the pan-caspase inhibitor zVAD-fmk in the BV2 murine microglia cell line. More importantly, mice exposed to MPTP and further treated with Oxa12 showed protection against MPTP-induced dopaminergic neuronal loss in the SN and striatum. In conclusion, we identified Oxa12 as a hit compound that represents a new chemotype to tackle necroptosis. Oxa12 displays in vivo effects, making this compound a drug candidate for further optimization to attenuate PD pathogenesis.
- 1 January 2017
- Published by Elsevier in Tetrahedron Letters
- Vol. 58 (4) , 302-304
Synthesis of trans-4,5-diaminocyclopent-2-enones from furfural catalyzed by Er(III) immobilized on silica
- 1 January 2017
- Published by Elsevier in Tetrahedron Letters
- Vol. 58 (4) , 302-304
Synthesis of trans-4,5-diaminocyclopent-2-enones from furfural catalyzed by Er(III) immobilized on silica
- 1 August 2016
- Published by Elsevier in Separation and Purification Technology
- Vol. 168, 74-82
Effect of water activity on carbon dioxide transport in cholinium-based ionic liquids with carbonic anhydrase
- 1 August 2016
- Published by Elsevier in Separation and Purification Technology
- Vol. 168, 74-82
Effect of water activity on carbon dioxide transport in cholinium-based ionic liquids with carbonic anhydrase
- 1 August 2012
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 54, 823-833
Indole based cyclooxygenase inhibitors: Synthesis, biological evaluation, docking and NMR screening
- 1 August 2012
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 54, 823-833
Indole based cyclooxygenase inhibitors: Synthesis, biological evaluation, docking and NMR screening
- 20 February 2012
- Published by Elsevier in Tetrahedron Letters
- Vol. 53 (16) , 2132-2136
Unexpected reactivity of trifluoromethylated olefins with indole: a mechanistic investigation
- 20 February 2012
- Published by Elsevier in Tetrahedron Letters
- Vol. 53 (16) , 2132-2136
Unexpected reactivity of trifluoromethylated olefins with indole: a mechanistic investigation
- 1 January 2011
- Published by Elsevier in Tetrahedron Letters
- Vol. 52 (1) , 101-106
Analysis of the antioxidant activity of an indole library: cyclic voltammetry versus ROS scavenging activity
- 1 January 2011
- Published by Elsevier in Tetrahedron Letters
- Vol. 52 (1) , 101-106
Analysis of the antioxidant activity of an indole library: cyclic voltammetry versus ROS scavenging activity
- 1 November 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (22) , 6475-6478
A new insight on the hypochlorous acid scavenging mechanism of tryptamine and tryptophan derivatives
- 1 November 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (22) , 6475-6478
A new insight on the hypochlorous acid scavenging mechanism of tryptamine and tryptophan derivatives
- 1 November 2010
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 45 (11) , 4869-4878
Antioxidant activity of unexplored indole derivatives: Synthesis and screening
- 1 November 2010
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 45 (11) , 4869-4878
Antioxidant activity of unexplored indole derivatives: Synthesis and screening
- 10 February 2010
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 2010 (05) , 753-756
A Simple Route Toward New Clomiphene Metabolites
A new clomiphene metabolite, extremely useful for doping analysis, was synthesized in 19% overall yield. The approach involved a Grignard reaction via a N-acylbenzotriazole intermediate to afford a key aromatic ketone and a HWE reaction. Both stereoisomers were separated and identified.
- 10 February 2010
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 2010 (05) , 753-756
A Simple Route Toward New Clomiphene Metabolites
A new clomiphene metabolite, extremely useful for doping analysis, was synthesized in 19% overall yield. The approach involved a Grignard reaction via a N-acylbenzotriazole intermediate to afford a key aromatic ketone and a HWE reaction. Both stereoisomers were separated and identified.